methane has been researched along with meglumine antimoniate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubota, LT; Santos, VS; Santos, Wde J; Tarley, CR | 1 |
| Akhtari, J; Bastani, R; Beydokhti, AK; Fakhar, M; Faridnia, R; Kalani, H; Rezvan, H | 1 |
2 other study(ies) available for methane and meglumine antimoniate
| Article | Year |
|---|---|
Speciation of Sb(III) and Sb(V) in meglumine antimoniate pharmaceutical formulations by PSA using carbon nanotube electrode.
Topics: Antimony; Chemistry, Pharmaceutical; Electrodes; Hydrogen-Ion Concentration; Meglumine; Meglumine Antimoniate; Nanotubes, Carbon; Organometallic Compounds; Osmolar Concentration; Potentiometry | 2009 |
Potent in vitro antileishmanial activity of a nanoformulation of cisplatin with carbon nanotubes against Leishmania major.
Topics: Antiprotozoal Agents; Cisplatin; Inhibitory Concentration 50; Leishmania major; Life Cycle Stages; Meglumine Antimoniate; Nanotubes, Carbon | 2019 |